These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33975311)

  • 1. The Impact of Platinum-Containing Chemotherapies in Advanced Triple-Negative Breast Cancer: Meta-Analytical Approach to Evaluating Its Efficacy and Safety.
    Yang R; Shi YY; Han XH; Liu S
    Oncol Res Treat; 2021; 44(6):333-343. PubMed ID: 33975311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of platinum-based and non-platinum-based drugs on triple-negative breast cancer: meta-analysis.
    Lin C; Cui J; Peng Z; Qian K; Wu R; Cheng Y; Yin W
    Eur J Med Res; 2022 Oct; 27(1):201. PubMed ID: 36242046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple negative breast cancer and platinum-based systemic treatment: a meta-analysis and systematic review.
    Pandy JGP; Balolong-Garcia JC; Cruz-Ordinario MVB; Que FVF
    BMC Cancer; 2019 Nov; 19(1):1065. PubMed ID: 31703646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antitumor treatments on triple-negative breast cancer patients: A PRISMA-compliant network meta-analysis of randomized controlled trials.
    Tian Q; Du P; Li S; Bai Z; Yang Y; Zeng J
    Medicine (Baltimore); 2017 Nov; 96(45):e8389. PubMed ID: 29137021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of platinum-based chemotherapy on the prognosis of early triple-negative breast cancer: a systematic review and meta-analysis.
    Zhao F; Shen G; Dong Q; Xin Y; Huo X; Wang M; Liu Z; Zhao Y; Ren D; Xie Q; Liu Z; Li Z; Gao L; Du F; Zhao J
    Clin Exp Med; 2023 Oct; 23(6):2025-2040. PubMed ID: 36422737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of continuous infusion of Rh-endostatin combined with platinum-based chemotherapy for advanced triple-negative breast cancer.
    Tan A; Wang H; Nong L; Jia Y; Liu Y; Zhong W; Qin F; Wang H; Tang J; Zhou W; Lu Y; Xie W
    Ann Palliat Med; 2021 Dec; 10(12):12101-12112. PubMed ID: 35016411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum-based chemotherapy in triple-negative breast cancer: A meta-analysis.
    Liu M; Mo QG; Wei CY; Qin QH; Huang Z; He J
    Oncol Lett; 2013 Mar; 5(3):983-991. PubMed ID: 23426861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of PD-1/PD-L1 inhibitors in triple-negative breast cancer: a systematic review and meta-analysis.
    Zhang M; Song J; Yang H; Jin F; Zheng A
    Acta Oncol; 2022 Sep; 61(9):1105-1115. PubMed ID: 35939538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum-based chemotherapy in triple-negative advanced breast cancer.
    Villarreal-Garza C; Khalaf D; Bouganim N; Clemons M; Peña-Curiel O; Baez-Revueltas B; Kiss A; Kassam F; Enright K; Verma S; Pritchard K; Myers J; Dent R
    Breast Cancer Res Treat; 2014 Aug; 146(3):567-72. PubMed ID: 25001611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pembrolizumab plus chemotherapy for first-line treatment of advanced triple-negative breast cancer.
    Haiderali A; Huang M; Pan W; Akers KG; Maciel D; Frederickson AM
    Future Oncol; 2024; 20(22):1587-1600. PubMed ID: 38597713
    [No Abstract]   [Full Text] [Related]  

  • 11. Platinum-based adjuvant therapy was efficient for triple-negative breast cancer: a meta-analysis from randomized controlled trials.
    Xie K; Ren X; Hong X; Zhu S; Wang D; Ye X; Ren X
    Bioengineered; 2022 Jun; 13(6):14827-14839. PubMed ID: 36278891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy for Metastatic Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.
    Lu F; Hou Y; Chen Z; Jiang J; He X; Xia Y; Cao K; Chang L; Li W
    Technol Cancer Res Treat; 2021; 20():15330338211016369. PubMed ID: 33977814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis.
    Poggio F; Bruzzone M; Ceppi M; Pondé NF; La Valle G; Del Mastro L; de Azambuja E; Lambertini M
    Ann Oncol; 2018 Jul; 29(7):1497-1508. PubMed ID: 29873695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the efficacy and safety of cisplatin and other platinum-based chemotherapies in locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis.
    Li Z; Li C; Yang D; Song J; Liu T; Zhou Z; Zhou L; Kang M
    BMC Cancer; 2022 Jun; 22(1):616. PubMed ID: 35668431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
    Rinnerthaler G; Gampenrieder SP; Petzer A; Burgstaller S; Fuchs D; Rossmann D; Balic M; Egle D; Rumpold H; Singer CF; Bartsch R; Petru E; Melchardt T; Ulmer H; Mlineritsch B; Greil R
    BMC Cancer; 2018 Nov; 18(1):1074. PubMed ID: 30400780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison.
    Lobefaro R; Mariani L; Peverelli G; Ligorio F; Fucà G; Rametta A; Zattarin E; Leporati R; Presti D; Cantarelli B; Depretto C; Vingiani A; Manoukian S; Scaperrotta G; Bianchi GV; Capri G; Pruneri G; de Braud F; Vernieri C
    Clin Breast Cancer; 2023 Apr; 23(3):e151-e162. PubMed ID: 36599769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum-based neoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis.
    Li ZY; Zhang Z; Cao XZ; Feng Y; Ren SS
    J Int Med Res; 2020 Oct; 48(10):300060520964340. PubMed ID: 33100072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Platinum-Based Treatment for Triple Negative Metastatic Breast Cancer: a Meta-Analysis.
    Kaya V; Yildirim M; Yazici G; Gunduz S; Bozcuk H; Paydas S
    Asian Pac J Cancer Prev; 2018 May; 19(5):1169-1173. PubMed ID: 29801396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platinum-based chemotherapy in advanced triple-negative breast cancer: A multicenter real-world study in China.
    Chen Y; Guan Y; Wang J; Ma F; Luo Y; Chen S; Zhang P; Li Q; Cai R; Li Q; Mo H; Lan B; Chen X; Zhao W; Xu B; Fan Y
    Int J Cancer; 2020 Dec; 147(12):3490-3499. PubMed ID: 32588429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current treatment landscape for patients with locally recurrent inoperable or metastatic triple-negative breast cancer: a systematic literature review.
    Li CH; Karantza V; Aktan G; Lala M
    Breast Cancer Res; 2019 Dec; 21(1):143. PubMed ID: 31842957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.